Chimeric Therapeutics Ltd. (AU:CHM) has released an update.
Chimeric Therapeutics Limited has announced the issuance of 18,211,683 unquoted equity securities under the code CHMAY, which are options expiring at various dates and prices. The securities are part of an employee incentive scheme and are not intended to be quoted on the ASX. This development, dated August 30, 2024, indicates potential growth and investment opportunities within the company.
For further insights into AU:CHM stock, check out TipRanks’ Stock Analysis page.
